Savant Capital
ZBH icon

Savant Capital’s Zimmer Biomet ZBH Stock Holding History

Savant Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$430K Sell
4,846
-523
-10% -$49.6K ﹤0.01% 1659
2026
Q2 		$475K Buy
5,369
+1,398
+35% +$123K ﹤0.01% 1249
2026
Q1 		$359K Sell
3,971
-124
-3% -$11.4K ﹤0.01% 1084
2025
Q4 		$368K Sell
4,095
-193
-5% -$18.3K ﹤0.01% 958
2025
Q3 		$422K Buy
4,288
+247
+6% +$24.5K ﹤0.01% 865
2025
Q2 		$369K Buy
4,041
+59
+1% +$5.7K ﹤0.01% 872
2025
Q1 		$451K Buy
3,982
+205
+5% +$21.9K ﹤0.01% 700
2024
Q4 		$399K Sell
3,777
-910
-19% -$97.6K ﹤0.01% 975
2024
Q3 		$506K Buy
+4,687
New +$512K ﹤0.01% 864
2024
Q2 		– Sell
-6,785
Closed -$895K – 1350
2024
Q1 		$895K Buy
6,785
+4,804
+243% +$600K 0.01% 575
2023
Q4 		$241K Sell
1,981
-248
-11% -$27.7K ﹤0.01% 762
2023
Q3 		$250K Sell
2,229
-170
-7% -$21.6K ﹤0.01% 706
2023
Q2 		$349K Buy
2,399
+65
+3% +$8.83K 0.01% 606
2023
Q1 		$302K Buy
2,334
+214
+10% +$26.9K 0.01% 591
2022
Q4 		$270K Sell
2,120
-107
-5% -$12.4K 0.01% 491
2022
Q3 		$233K Buy
2,227
+24
+1% +$2.63K 0.01% 479
2022
Q2 		$231K Buy
2,203
+11
+0.5% +$1.3K 0.01% 493
2022
Q1 		$280K Buy
2,192
+427
+24% +$51.5K 0.01% 469
2021
Q4 		$218K Sell
1,765
-2
-0.1% -$262 0.01% 527
2021
Q3 		$251K Buy
1,767
+107
+6% +$15.7K 0.01% 455
2021
Q2 		$259K Buy
1,660
+44
+3% +$7.13K 0.01% 425
2021
Q1 		$251K Sell
1,616
-50
-3% -$7.74K 0.01% 401
2020
Q4 		$249K Sell
1,666
-82
-5% -$11.6K 0.01% 386
2020
Q3 		$231K Sell
1,748
-106
-6% -$13.8K 0.02% 358
2020
Q2 		$215K Sell
1,854
-561
-23% -$64.6K 0.02% 369
2020
Q1 		$237K Buy
2,415
+1,005
+71% +$132K 0.02% 334
2019
Q4 		$205K Buy
+1,410
New +$195K 0.03% 337
2015
Q4 		– Sell
-2,338
Closed -$213K – 228
2015
Q3 		$213K Buy
+2,338
New +$234K 0.08% 193

Other funds holding ZBH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Sound Shore Management
Sound Shore Management Greenwich, Connecticut $3.2B AUM 19.02% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Savant Capital's ZBH Position: Q3 2026 in Review

Savant Capital reduced its Zimmer Biomet (ZBH) stake by 9.7% in Q3 2026, selling an estimated $49.6K and leaving 4,846 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Savant Capital first reported a position in ZBH in Q3 2015 and has held it in 28 quarters since. The position peaked at $895K in Q1 2024. 545 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Savant Capital held 4,846 shares of Zimmer Biomet worth $430K as of Q3 2026.
  • Savant Capital sold 523 Zimmer Biomet shares in Q3 2026, an estimated $49.6K.
  • Zimmer Biomet made up ﹤0.01% of Savant Capital's portfolio in Q3 2026, its #1659 holding.
  • Savant Capital first reported a position in Zimmer Biomet in Q3 2015 and has held it in 28 quarters since.
  • Savant Capital's Zimmer Biomet position peaked at $895K in Q1 2024.
  • 545 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.